![Sharecast News](https://static.lse.co.uk/images/news-logos/sharecast-news-logo.png)
US FDA approves GSK treatment for myelofibrosis
(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.
Read more